Search Results for 'Her2'

Her2 published presentations and documents on DocSlides.

Metastatic HER2-Positive Breast Cancer: Treatment Selection

Metastatic HER2-Positive Breast Cancer: Treatment Selection

by test

First . Line and Beyond. Moderator:. Joseph Gligo...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

HER2 TESTING IN BREAST CANCER

HER2 TESTING IN BREAST CANCER

by danika-pritchard

Clinical Practice Guideline Update. American Soci...

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

Updates on the Use of Adjuvant Therapy in HER2-Positive Breast Cancer

by danika-pritchard

ASCO-CAP Recommendations For HER2 Testing in Brea...

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

Management of HER2 Over-Expressed Breast Cancer in the Adjuvant, Neoadjuvant, and Metastatic settings

by marina-yarberry

Management of HER2 Over-Expressed Breast Cancer i...

Module 9: HER2-Positive and

Module 9: HER2-Positive and

by norah

Triple-Negative Breast Cancer. Jamie Carroll, APRN...

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

HER2 positive breast carcinoma in the pre and post adjuvant anti-HER-2 therapy era: a single academ

by carny

Heather M. Gage, MD, Avanti . Rangnekar. , Robert ...

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

HER2 and Ki67Assessment of regional lymph nodesPhysical examination

by arya

Luminal B-like (HER2-positive):!ER-positive!HER2-p...

Her2 + Breast Cancer Laura

Her2 + Breast Cancer Laura

by ximena

Bidstrup. Mrs B is a 49 . yo. woman who attended ...

What’s new in Anatomic Pathology Quality Assurance?

What’s new in Anatomic Pathology Quality Assurance?

by alida-meadow

. Raouf E. Nakhleh, MD. Mayo Clinic Florida. Dis...

by tawny-fly

Gradishar. . MD, FACP. Betsy . Bramsen. Profess...

ID DB06366 CATEGORY

ID DB06366 CATEGORY

by luanne-stotts

Monoclonal antibodies . PERTUZUMAB . 148 . kDa. ...

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

Tumor Marker Phenotype Concordance in Second Primary Breast Cancer

by debby-jeon

Monica Brown, MPH, PhD. . California Cancer Regi...

Metastatic Breast Cancer: A Medical Update

Metastatic Breast Cancer: A Medical Update

by liane-varnes

Jennifer M. Matro, MD. Rena Rowan Breast Center. ...

Updates in the Treatment of Breast cancer

Updates in the Treatment of Breast cancer

by alexa-scheidler

Mohammad . Jahanzeb. , MD, FACP. Professor of Cli...

Endocrine resistance: molecular pathways and rational development of targeted therapies

Endocrine resistance: molecular pathways and rational development of targeted therapies

by spottletoefacebook

Grazia Arpino. Università di Napoli Federico II. ...

Product Pipeline Neratinib

Product Pipeline Neratinib

by coursion

across the breast cancer therapy spectrum. Phase I...

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

6'DakoHercepTestTM for the Dako AutostainerCode K52071st editionFor im

by katrgolden

Contents PageIntended Use 4Summary and Explanation...

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

Snyder D, Heidel RE, Panella T, Bell J, Orucevic

by Kingslayer

A. University of Tennessee Medical Center – Knox...

Nanotek & Expo 2014

Nanotek & Expo 2014

by DaintyLittlePrincess

Biodegradable . nanobrushes. for drug delivery. ...

ORIGINALARTICLEBREASTONCOLOGY

ORIGINALARTICLEBREASTONCOLOGY

by emery

SentinelLymphNodeBiopsyAfterNeoadjuvantChemotherap...

Central Asian Journal of

Central Asian Journal of

by cady

15 Medical and Pharmaceutical Sciences Innovation ...

Antibody–Drug Conjugates in Development for Non-

Antibody–Drug Conjugates in Development for Non-

by elizabeth

s. mall Cell . Lung Cancer. , Gastric Cancer, and ...

Antibody–Drug Conjugates

Antibody–Drug Conjugates

by wang

in Development for . Breast Cancer. Sara A. Hurvit...

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

Antibody–Drug Conjugates: Practical Considerations and Applications in Clinical Use

by gelbero

Sara A. Hurvitz, MD, FACP. Professor of Medicine. ...

Denise A. Yardley, MD Sarah Cannon Research Institute

Denise A. Yardley, MD Sarah Cannon Research Institute

by lily

Senior Investigator, . Breast Cancer Research. Ten...

CA BREAST D r S ana

CA BREAST D r S ana

by oconnor

ishtiaq. . FCPS R3 general surgery unit one UKSO...

Changes in Breast Cancer Reports After Second Opinion

Changes in Breast Cancer Reports After Second Opinion

by unita

Dr. Vicente Marco. Department of Pathology. Hospit...

2020 Year in Review: Breast Cancer

2020 Year in Review: Breast Cancer

by caroline

Lisa A. Carey MD, . ScM. University of North Carol...

Module 9: HER2-Positive and Triple-Negative BC

Module 9: HER2-Positive and Triple-Negative BC

by unita

Percent with Patients. Number of Patients (Median)...

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

Mauricio Lema Medina – Clínica de Oncología Astorga / Clínica SOMA, Medellín

by delcy

Trastuzumab-emtansine. : A . very. . nice. . poi...

Metastatic triple-positive

Metastatic triple-positive

by marcos147

breast. . cancer. . needs. . different. . ther...

Managing Breast Cancer in the Genomic Era

Managing Breast Cancer in the Genomic Era

by alida-meadow

Leisha. A. . Emens. , M.D., . Ph.D. Associate Pr...

Translating NGS Data into a Clinically Actionable Assay

Translating NGS Data into a Clinically Actionable Assay

by danika-pritchard

Elaine R. Mardis, Ph.D.. Professor of Genetics. C...

Evaluation of HR[ER/

Evaluation of HR[ER/

by debby-jeon

PgR. ] status and correlation with Ki67 expres...

Chemotherapeutic Treatment Options for Triple Negative Brea

Chemotherapeutic Treatment Options for Triple Negative Brea

by lois-ondreau

Lauren Barney. April 17, 2013. Breast Cancer Subt...

New Therapies for Metastatic Breast Cancer

New Therapies for Metastatic Breast Cancer

by alexa-scheidler

Sigrun Hallmeyer, MD. Oncology Specialists, SC. D...

RESEARCHARTICLEOpenAccess

RESEARCHARTICLEOpenAccess

by alida-meadow

Proposednewclinicopathologicalsurrogate definition...

At the Forefront of Immunotherapy

At the Forefront of Immunotherapy

by karlyn-bohler

OTCQB: TPIV. 1551 Eastlake Ave E. Suite 100. Seat...

Breast Cancer Highlights From San Antonio

Breast Cancer Highlights From San Antonio

by tatyana-admore

Joyce O'Shaughnessy, MD. Kimberly Blackwell, MD. ...